Login here to update your profile  
My Profile

Donna Eason, PHD


Assistant Professor

Assoc Professor

profile Image
Email: dberry@health.usf.edu
Office: ACH, CRI3008
  • PHD, University Of South Florida, United States - 2000.

    Selected Publications
  • Cannon JP, Haire RN, Magis AT, Eason DD, Winfrey KN, Hernandez Prada JA, Bailey KM, Jakoncic J, Litman GW, Ostrov DA. A bony fish immunological receptor of the NITR multigene family mediates allogeneic recognition. Immunity. 29(2) : 228-37, 2008.
  • Litman GW, Cannon JP, Dishaw LJ, Haire RN, Eason DD, Yoder JA, Prada JH, Ostrov DA. Immunoglobulin variable regions in molecules exhibiting characteristics of innate and adaptive immune receptors. Immunologic research. 38(1-3) : 294-304, 2007.
  • Cannon JP, Haire RN, Mueller MG, Litman RT, Eason DD, Tinnemore D, Amemiya CT, Ota T, Litman GW. Ancient divergence of a complex family of immune-type receptor genes. Immunogenetics. 58(5-6) : 362-73, 2006.
  • Eason DD, Cannon JP, Haire RN, Rast JP, Ostrov DA, Litman GW. Mechanisms of antigen receptor evolution. Seminars in immunology. 16(4) : 215-26, 2004.
  • Eason DD, LeBron C, Coppola D, Moscinski LC, Livingston S, Sutton ET, Blanck G. Development of CD30+ lymphoproliferative disease in mice lacking interferon regulatory factor-1. Oncogene. 22(40) : 6166-76, 2003.
  • Yoder JA, Hawke NA, Eason DD, Mueller MG, Davids BJ, Gillin FD, Litman GW. BIVM, a novel gene widely distributed among deuterostomes, shares a core sequence with an unusual gene in Giardia lamblia. Genomics. 79(6) : 750-5, 2002.
  • Eason DD, Coppola D, Livingston S, Shepherd AT, Blanck G. Loss of MHC class II inducibility in hyperplastic tissue in Rb-defective mice. Cancer letters. 171(2) : 209-14, 2001.
  • Goodwin BL, Xi H, Tejiram R, Eason DD, Ghosh N, Wright KL, Nagarajan U, Boss JM, Blanck G. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines. Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research. 12(6) : 327-35, 2001.
  • Eason DD, Blanck G. High level class II trans-activator induction does not occur with transient activation of the IFN-gamma signaling pathway. Journal of immunology (Baltimore, Md. : 1950). 166(2) : 1041-8, 2001.
  • Xi H, Eason DD, Ghosh D, Dovhey S, Wright KL, Blanck G. Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2. Oncogene. 18(43) : 5889-903, 1999.
  • Zhang H, Shepherd AT, Eason DD, Wei S, Diaz JI, Djeu JY, Wu GD, Blanck G. Retinoblastoma protein expression leads to reduced Oct-1 DNA binding activity and enhances interleukin-8 expression. Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research. 10(7) : 457-65, 1999.
  • Eason DD, Shepherd AT, Blanck G. Interferon regulatory factor 1 tryptophan 11 to arginine point mutation abolishes DNA binding. Biochimica et biophysica acta. 1446(1-2) : 140-4, 1999.

  • Profile last modified on 05/15/2012